RNU7-123P

Across TCGA pan-cancer cohorts, RNU7-123P RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated RNU7-123P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU7-123P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-123P expression acts as an unfavorable survival marker, although some lineages such as SKCM and LUAD show a favorable association.

ACC, SKCM, and LUAD are the cancer types where RNU7-123P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.568	0.880	.002	33	view →
SKCM	OS	Tertile	All	0.429	0.271	.002	28	view →
LUAD	OS	Tertile	All	0.485	0.188	<.001	25	view →
LIHC	DFS	Median	All	0.376	0.501	.009	25	view →
LGG	DFS	Quartile	All	0.723	0.920	.005	22	view →
OV	OS	Median	IV	0.634	0.849	.007	10	view →
UCS	OS	Median	IV	0.693	0.262	.047	6	view →
HNSC	OS	Tertile	All	0.595	0.772	.006	6	view →
PAAD	DFS	Tertile	III,IV	0.338	0.893	.038	6	view →
CESC	DFS	Median	IV	0.328	0.634	.043	6	view →
PRAD	OS	Median	All	0.818	0.991	.015	6	view →
BLCA	OS	Tertile	All	0.696	0.564	.037	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

RNU7-123P–ACC (DFS)

Open the ACC breakdown →